Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Hepatitis C/ complications"'
Autor:
Ana de Lourdes Candolo Martinelli, Andreza Correa Teixeira, Fernanda Fernandes Souza, Ajith Kumar Sankarankutty, Orlando de Castro e Silva
Publikováno v:
Acta Cirúrgica Brasileira, Vol 21, Pp 15-18 (2006)
Hepatitis C is the main cause of cirrhosis and hepatocellular carcinoma and the leading indication of liver transplantation. The aim of this article was to review specific epidemiological, clinical and therapeutic aspects of hepatitis C and theirs im
Externí odkaz:
https://doaj.org/article/0f569dd9f97946de8bd243d0adc17809
Autor:
Cuba, Jefferson Wrublack, Anjos, Amanda da Silva, Toderke, Edimar Leandro, Kwiatkowski, Filipe Vieira
Publikováno v:
Revista Brasileira de Cancerologia; Vol. 67 No. 2 (2021): Apr./May/June; e-121220
Revista Brasileira de Cancerologia; Vol. 67 Núm. 2 (2021): abr./mayo/jun.; e-121220
Revista Brasileira de Cancerologia; v. 67 n. 2 (2021): abr./maio/jun.; e-121220
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
Revista Brasileira de Cancerologia; Vol. 67 Núm. 2 (2021): abr./mayo/jun.; e-121220
Revista Brasileira de Cancerologia; v. 67 n. 2 (2021): abr./maio/jun.; e-121220
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
Introduction: Hepatitis C is associated with the development of hepatocellular carcinoma (HCC). The interferon-based therapeutic regimen has been replaced by direct-acting antivirals (AAD) to treat HCV virus infection. However, recent studies have sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::6899ab7d9a84346a560834b9f4b07f39
https://rbc.inca.gov.br/index.php/revista/article/view/1220
https://rbc.inca.gov.br/index.php/revista/article/view/1220
Autor:
Nicolas Müller, M. Huber, Barbara Hasse, Matthias Hoffmann, Christoph Rudin, Thierry Calandra, Gladys Martinetti, Thomas Klimkait, A. Anagnostopoulos, Helen Kovari, Catia Marzolini, Enos Bernasconi, B Martinez de Tejada, Laurent Kaiser, Karin J. Metzner, Tytti Heinonen, Dominique L Braun, M. Cavassini, Giuseppe Pantaleo, P. Vernazza, Philip E. Tarr, Jürg Böni, Irene T. Schrijver, Marcel Stöckle, Jacques Fellay, Manuel Battegay, Khalid Ohmiti, K. Aebi-Popp, D Haerry, Rainer Weber, Alexandra U. Scherrer, G. Dollenmaier, Hansjakob Furrer, Thierry Roger, Jacobus Herderschee, Christian R Kahlert, Angela Ciuffi, Günthard Hf, Craig Fenwick, Hans H. Hirsch, A. Calmy, Andri Rauch, Irene Hösli, M. Perreau, A. Trkola, Patrick Schmid, Christoph A Fux, G. Pantaleo, Matthias Cavassini, Paolo Paioni, Sabine Yerly, Roger D. Kouyos, Jan Fehr, Olivia Keiser, Dunja Nicca, M Egger, L Elzi, Darius Moradpour, Gilles Wandeler, B Ledergerber, Roberto F. Speck, Heiner C. Bucher
Publikováno v:
Clinical microbiology and infection, vol. 28, no. 4, pp. 611.e1-611.e7
Objectives Chronic hepatitis C virus (HCV) infection affects the immune system. Whether elimination of HCV with direct-acting antivirals (DAA) restores immunity is unclear. We used mass cytometry to get a broad and in-depth assessment of blood cell p
Autor:
Vincent Lam, Tao Wei, Luca Aldrighetti, Olivier Soubrane, Hugo Marques, Guillaume Martel, Aklile Workneh, Xu Feng Zhang, Fabio Bagante, Alfredo Guglielmi, Irinel Popescu, Timothy M. Pawlik, Thomas J. Hugh, Francesca Ratti, George A. Poultsides, Sorin Alexandrescu
Background: To define the chronological changes of long-term survival among patients with non-hepatitis-related hepatocellular carcinoma (Non-Hep-HCC) versus hepatitis C-related HCC (HCV-HCC) over the last two decades. Methods: Patients who underwent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba7ce810fd3af230158dbeaaca342ad3
https://hdl.handle.net/10400.17/4431
https://hdl.handle.net/10400.17/4431
Autor:
Teymur Noori, Joerg J Meerpohl, Lukas P. Staub, Anh Tran, Kevin Pottie, Rachael L. Morton, Robin Christensen, Adam Palayew, Iuliia Makarenko, Christina Greenaway, Manish Pareek, Balqis Alabdulkarim, Francesco Castelli, Claire Nour Abou Chakra, Irene Veldhuijzen
Publikováno v:
International Journal of Environmental Research and Public Health
Greenaway, C, Makarenko, I, Chakra, C N A, Alabdulkarim, B, Christensen, R, Palayew, A, Tran, A, Staub, L, Pareek, M, Meerpohl, J J, Noori, T, Veldhuijzen, I, Pottie, K, Castelli, F & Morton, R L 2018, ' The effectiveness and cost-effectiveness of hepatitis c screening for migrants in the EU/EEA : A systematic review ', International Journal of Environmental Research and Public Health, vol. 15, no. 9, 2013 . https://doi.org/10.3390/ijerph15092013
International Journal of Environmental Research and Public Health, Vol 15, Iss 9, p 2013 (2018)
Greenaway, C, Makarenko, I, Chakra, C N A, Alabdulkarim, B, Christensen, R, Palayew, A, Tran, A, Staub, L, Pareek, M, Meerpohl, J J, Noori, T, Veldhuijzen, I, Pottie, K, Castelli, F & Morton, R L 2018, ' The effectiveness and cost-effectiveness of hepatitis c screening for migrants in the EU/EEA : A systematic review ', International Journal of Environmental Research and Public Health, vol. 15, no. 9, 2013 . https://doi.org/10.3390/ijerph15092013
International Journal of Environmental Research and Public Health, Vol 15, Iss 9, p 2013 (2018)
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (EU/EEA) and is a leading cause of chronic liver disease and liver cancer. Migrants account for a disproportionate number of HCV cases in the EU/EEA (m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572237efd779636a2d86f8a16d8befd9
http://hdl.handle.net/10029/622213
http://hdl.handle.net/10029/622213
Publikováno v:
BMC INFECTIOUS DISEASES
Stockdale, A J, Mitambo, C, Everett, D, Geretti, A M & Gordon, M A 2018, ' Epidemiology of hepatitis B, C and D in Malawi : systematic review ', BMC Infectious Diseases, vol. 18, no. 1, pp. 516 . https://doi.org/10.1186/s12879-018-3428-7
BMC Infectious Diseases
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Stockdale, A J, Mitambo, C, Everett, D, Geretti, A M & Gordon, M A 2018, ' Epidemiology of hepatitis B, C and D in Malawi : systematic review ', BMC Infectious Diseases, vol. 18, no. 1, pp. 516 . https://doi.org/10.1186/s12879-018-3428-7
BMC Infectious Diseases
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Background Viral hepatitis is an important public health issue in sub-Saharan Africa. Due to rising mortality from cirrhosis and hepatocellular carcinoma and limited implementation of screening and treatment programmes, it has been characterised as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::961f878bb50220fb4e41a3f728abc799
Autor:
Romero Henrique Carvalho Bertrand, Adriana Leite Xavier Bertrand, Thais Mota Gomes, Adalgisa de Sousa Paiva Ferreira
Publikováno v:
Arquivos Brasileiros de Oftalmologia v.82 n.2 2019
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
Arquivos Brasileiros de Oftalmologia, Vol 82, Iss 2, Pp 161-167 (2019)
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
Arquivos Brasileiros de Oftalmologia, Vol 82, Iss 2, Pp 161-167 (2019)
This review aims to caution ophthalmologists about the ocular consequences leading to the diagnosis of hepatitis C virus infection. In addition, in this context, the effects of old and new drugs are discussed in the ophthalmological setting. The impo
Autor:
Raphael Mohr, Christoph Boesecke, Evrim Anadol, Jürgen K. Rockstroh, Carolynne Schwarze-Zander, Jonel Trebicka, Jan-Christian Wasmuth, Kristina Lust
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191118 (2018)
PLoS ONE
Anadol, E, Lust, K, Boesecke, C, Schwarze-Zander, C, Mohr, R, Wasmuth, J-C, Rockstroh, J K & Trebicka, J 2018, ' Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients ', PLOS ONE, vol. 13, no. 1, e0191118 . https://doi.org/10.1371/journal.pone.0191118
PLoS ONE
Anadol, E, Lust, K, Boesecke, C, Schwarze-Zander, C, Mohr, R, Wasmuth, J-C, Rockstroh, J K & Trebicka, J 2018, ' Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients ', PLOS ONE, vol. 13, no. 1, e0191118 . https://doi.org/10.1371/journal.pone.0191118
INTRODUCTION: Combined antiretroviral therapy (cART) has improved survival in HIV-patients. While the first antiretrovirals, which became available in particular D-drugs (especially didanosine and stavudine) and unboosted protease inhibitors, may imp
Publikováno v:
PLoS ONE
PloS one, vol. 12, no. 10, pp. e0186715
PloS one, 12 (10
PloS one, Vol. 12, no. 10, p. e0186715 [1-16] (2017)
PLoS ONE, Vol 12, Iss 10, p e0186715 (2017)
PloS one, vol. 12, no. 10, pp. e0186715
PloS one, 12 (10
PloS one, Vol. 12, no. 10, p. e0186715 [1-16] (2017)
PLoS ONE, Vol 12, Iss 10, p e0186715 (2017)
Background: Cirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging stages of severity. The role of the underlying liver disease on patient prognosis remains unclear. Aim: To assess the impact of the underlying liver di
Publikováno v:
BMC Medicine
BMC Medicine, BioMed Central, 2017, 15 (1), ⟨10.1186/s12916-017-0815-7⟩
BMC Medicine, 2017, 15 (1), ⟨10.1186/s12916-017-0815-7⟩
BMC Medicine, BioMed Central, 2017, 15 (1), ⟨10.1186/s12916-017-0815-7⟩
BMC Medicine, 2017, 15 (1), ⟨10.1186/s12916-017-0815-7⟩
PMC5348895; Hepatitis C virus infection is a major cause of hepatocellular carcinoma worldwide. Interferon has been the major antiviral treatment, yielding viral clearance in approximately half of patients. New direct-acting antivirals substantially